J&J To Pay $23M To Settle Investors' Drug Recall Suit
Johnson & Johnson will pay $23 million to settle a shareholder class action alleging that the company failed to disclose manufacturing violations leading to the biggest recall of over-the-counter children's medicine...To view the full article, register now.
Already a subscriber? Click here to view full article